Lyvispah - NDC Database

6 records found

Page:1

64896-076 Jun 01, 2023
Lyvispah 5 mg Oral Granule by Amneal Pharmaceuticals LLC

64896-077 Jun 01, 2023
Lyvispah 10 mg Oral Granule by Amneal Pharmaceuticals LLC

64896-078 Jun 01, 2023
Lyvispah 20 mg Oral Granule by Amneal Pharmaceuticals LLC

70257-412 Nov 22, 2021
Lyvispah 5 mg Oral Granule by Saol Therapeutics Inc

70257-414 Nov 22, 2021
Lyvispah 10 mg Oral Granule by Saol Therapeutics Inc

70257-416 Nov 22, 2021
Lyvispah 20 mg Oral Granule by Saol Therapeutics Inc

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.